Zurich Cantonal Bank’s GSK GSK Stock Holding History

Zurich Cantonal Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.5K	Sell	716 -31	-4%	-$1.64K	﹤0.01%	2460
2026 Q1	$41.2K	Buy	+747	New	+$40.5K	﹤0.01%	2448
2025 Q4	–	Sell	-1,253	Closed	-$58.4K	–	2966
2025 Q3	$54.1K	Buy	+1,253	New	+$48.9K	﹤0.01%	2448
2025 Q1	–	Sell	-24	Closed	-$812	–	2648
2024 Q4	$812	Hold	24	–	–	﹤0.01%	2627
2024 Q3	$981	Hold	24	–	–	﹤0.01%	2642
2024 Q2	$924	Hold	24	–	–	﹤0.01%	2634
2024 Q1	$1.03K	Hold	24	–	–	﹤0.01%	2665
2023 Q4	$889	Hold	24	–	–	﹤0.01%	2701
2023 Q3	$870	Hold	24	–	–	﹤0.01%	2771
2023 Q2	$855	Hold	24	–	–	﹤0.01%	2776
2023 Q1	$854	Hold	24	–	–	﹤0.01%	2832
2022 Q4	$843	Hold	24	–	–	﹤0.01%	2838
2022 Q3	$1K	Hold	24	–	–	﹤0.01%	2899
2022 Q2	$1K	Sell	24 -70	-74%	-$3.86K	﹤0.01%	2886
2022 Q1	$5K	Hold	94	–	–	﹤0.01%	2714
2021 Q4	$5K	Hold	94	–	–	﹤0.01%	2898
2021 Q3	$5K	Buy	+94	New	+$4.72K	﹤0.01%	2815

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Zurich Cantonal Bank's GSK Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its GSK (GSK) stake by 4.1% in Q2 2026, selling an estimated $1.64K and leaving 716 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2460.

Zurich Cantonal Bank first reported a position in GSK in Q3 2021 and has held it in 17 quarters since. The position peaked at $54.1K in Q3 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Zurich Cantonal Bank held 716 shares of GSK worth $37.5K as of Q2 2026.
Zurich Cantonal Bank sold 31 GSK shares in Q2 2026, an estimated $1.64K.
GSK made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2460 holding.
Zurich Cantonal Bank first reported a position in GSK in Q3 2021 and has held it in 17 quarters since.
Zurich Cantonal Bank's GSK position peaked at $54.1K in Q3 2025.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.